Literature DB >> 3401739

Ketamine prevents ischemic neuronal injury.

F W Marcoux1, J E Goodrich, M A Dominick.   

Abstract

The dissociative anesthetic ketamine hydrochloride antagonizes the excitotoxic action of excitatory amino acids in the central nervous system. Proposals that the excitatory amino acid neurotransmitters may become excitotoxic and contribute to the pathophysiology of ischemic brain injury prompted us to examine ketamine in a model of global cerebral ischemia in gerbils. Pretreatment with anesthetic doses of ketamine ameliorated in a dose-dependent manner both behavioral and histopathological assessments of ischemic neuronal injury. These neuroprotective effects are proposed to result from a specific antiexcitotoxic rather than general anticonvulsant drug action. There may be clinical situations in which the neuroprotective actions of ketamine would be of therapeutic importance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401739     DOI: 10.1016/0006-8993(88)90037-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Pharmacokinetic-pharmacodynamic modelling of ketamine in six neurotraumatised intensive care patients.

Authors:  Youssef Hijazi; Carole Bodonian; François Salord; Françoise Bressolle; Roselyne Boulieu
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

2.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

3.  Ketamine concentrations during cardiopulmonary bypass.

Authors:  R F McLean; A J Baker; S E Walker; C D Mazer; B I Wong; E M Harrington
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

Review 4.  Considerations for the use of anesthetics in neurotoxicity studies.

Authors:  Sumedha W Karmarkar; Kathleen M Bottum; Shelley A Tischkau
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

Review 5.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

6.  Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.

Authors:  Stefan Braeuninger; Christoph Kleinschnitz
Journal:  Exp Transl Stroke Med       Date:  2009-11-25

7.  Ketamine in prehospital care.

Authors:  K Porter
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

8.  Proteomic Analysis of Cyclic Ketamine Compounds Ability to Induce Neural Differentiation in Human Adult Mesenchymal Stem Cells.

Authors:  Jerran Santos; Bruce Kenneth Milthorpe; Matthew Paul Padula
Journal:  Int J Mol Sci       Date:  2019-01-26       Impact factor: 5.923

9.  Ketamine ameliorates oxidative stress-induced apoptosis in experimental traumatic brain injury via the Nrf2 pathway.

Authors:  Jinwei Liang; Shanhu Wu; Wenxi Xie; Hefan He
Journal:  Drug Des Devel Ther       Date:  2018-04-16       Impact factor: 4.162

10.  Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells.

Authors:  Xiaohui Zhou; Jing Liu; Siyi Yang; Yanguang Su; Zhipeng Meng; Yuqin Hu
Journal:  Clinics (Sao Paulo)       Date:  2020-09-11       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.